Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor
US-2024402163-A1 · Dec 5, 2024 · US
Process for determining the susceptibility to nosocomial infections
US9823239B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9823239-B2 |
| Application number | US-201314387076-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 22, 2013 |
| Priority date | Mar 23, 2012 |
| Publication date | Nov 21, 2017 |
| Grant date | Nov 21, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to a process for determining the susceptibility to nosocomical infections in a patient, comprising the measurement of the expression of sCD127 in a biological sample.
First claim
Opening claim text (preview).
The invention claimed is: 1. A process for determining the susceptibility of a patient with septic shock to nosocomial infections, comprising the following steps: taking a first biological sample from said patient up to 48h after an onset of septic shock; taking a second biological sample from said patient at least 24h after the first biological sample is taken, and up to 10 days after the onset of septic shock; and measuring the expression of soluble CD127 in the first biolog…
Assignees
Inventors
Classifications
- G01N33/53Primary
Physics · mapped topic
- G01N33/54306Primary
Physics · mapped topic
Physics · mapped topic
Physics · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9823239B2 cover?
- The invention relates to a process for determining the susceptibility to nosocomical infections in a patient, comprising the measurement of the expression of sCD127 in a biological sample.
- Who is the assignee on this patent?
- Hospices Civils Lyon, Biomerieux Sa
- What technology area does this patent fall under?
- Primary CPC classification G01N33/53. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).